BRISTOL, Tenn., May 3 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. reported today that the Company will provide a live webcast of its conference call to be held following King’s announcement of earnings for the first quarter ended March 31, 2006. As previously announced, King plans to announce earnings for the first quarter ended March 31, 2006 prior to the market open on Tuesday, May 9, 2006.
Two Ways to Join the Live Event - Tuesday, May 9, 2006, 1:00 pm Eastern Daylight Time
Internet Webcast:
Click the following link to register, then join the live event with the same URL:
http://www.b2i.us/external.asp?b=1084&id=260&from=wc&L=e Telephone Audio Conference: Call in to the telephone conference up to 15 minutes early: Toll free in the United States 800-374-0113 Outside the United States 706-758-9607 Can’t Make the Live Event? Listen “On Demand":
If you are unable to participate during the live event, King will archive the call on its website www.kingpharm.com for not less than 14 days following the call. A replay of the conference call will also be available for not less than five days following the call by dialing 800-642-1687 (US only) or 706- 645-9291 (international), passcode 8823517.
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.
About Forward-Looking Statements
This release contains forward-looking statements which reflect management’s current views of future events and operations, including, but not limited to, statements pertaining to the anticipated live webcast of the Company’s presentation. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward-looking statements. Some important factors which may cause results to differ include dependence on King’s ability to conduct its webcast as currently planned on May 9, 2006. Other important factors that may cause actual results to differ materially from the forward-looking statements are discussed in the “Risk Factors” section and other sections of King’s Form 10-K for the year ended December 31, 2005 which is on file with the Securities and Exchange Commission. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.
King Pharmaceuticals, Inc.
CONTACT: James E. Green, Executive Vice President, Corporate Affairs,+1-423-989-8125, or David E. Robinson, Senior Director, Corporate Affairs,+1-423-989-7045, both of King Pharmaceuticals, Inc.
Company News On-Call: http://www.prnewswire.com/comp/120319.html/
